SpicyIP

MARCH 11, 2024

Highlights of the Week Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes Patent Infringement Case Image from [link] here Recently, the DHC issued directives regarding expert evidence in the Perjeta patent litigation. Anything we are missing out on? Please let us know in the comments below.

Trademark 59

Trademark Registration Copyright Patent 59

The IPKat

SEPTEMBER 12, 2021

A primary motivation for Abbott's expedition application was to obtain a UK court decision on the validity of four European patents in order to influence a German court considering infringement of the German EP equivalents and to prevent the problems of the "injunction gap". Libre 2 was launched in October 2020.

Litigation 98

Litigation Patent Marketing Marketing 98

Patently-O

FEBRUARY 22, 2023

Patent assertion finance today is a multibillion-dollar business. [2] 2] Virtually nonexistent in the patent space in the U.S. It generally amounts to more than 50% of the total settlement recovery, acknowledging, at least by basic math, that they are the primary beneficiary of the litigation.).

Litigation 125

Litigation Reporting Settlement Government 125

LexBlog IP

FEBRUARY 2, 2023

This is the latest in the series titled “NPE Showcase,” where we discuss high-volume non-practicing entities (or as some call them, “patent trolls”). Large tech companies take a close look at their patent portfolio to determine which dormant assets may be sold off without affecting company performance.

Litigation 40

Litigation Patent Troll Settlement Technology 40

LexBlog IP

APRIL 3, 2023

Further, during five years of negotiation between the parties before Intex filed the CCI complaint, Ericsson had provided to Intex claim charts showing essentiality and a test report showing infringement. Ericsson argued that, under the 2015 EU decision in Huawei v. ” The Court also distinguished a recent UK Interdigital v.

Licensing 52

Licensing Technology Intellectual Property Patent 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

The biosimilar market also exhibited continued growth, with multiple biosimilar developers reporting strong sales of biosimilars through 2021. With respect to commercial launches, the United States saw fewer new biosimilars entering the market in 2021 than in previous years. No earlier than 2023 per settlement. Introduction.

Litigation 52

Litigation Settlement Patent Marketing 52

LexBlog IP

JUNE 7, 2023

In principle, transparency is desirable, to the extent it allows implementers to predict the licensing costs of marketing standard-compliant products. 27] The purpose of the report is therefore twofold: to encourage settlement and to provide transparency on the process and recommended FRAND in cases of disagreement. [28]

Licensing 52

Licensing Patent Confidentiality Registration 52